Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Marico, Sun Pharma; sell HDFC Bank: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying Marico and Sun Pharma and advises selling HDFC Bank.

    • Prefer SKS Micro: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may prefer SKS Microfinance.

    • Buy Sun Pharma, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharma as the stock is an outperformer from the pharma space.

    • Buy Sun Pharma, target Rs 800: Chandan Taparia

      Chandan Taparia, Derivative & Technical Analyst at Anand Rathi Securities recommends buying Sun Pharmaceutical Industries with a target of Rs 800.

    • Tata Steel may test Rs 251, Sun Pharma Rs 815: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that Tata Steel may test Rs 251 and Sun Pharma may test Rs 815.

    • Prefer Sun Pharma, Lupin on correction: Ambareesh Baliga

      Ambareesh Baliga, Independent Market Expert is of the view that one may prefer Sun Pharma and Lupin on correction.

    • Prefer pharma stocks, says Dipan Mehta

      Dipan Mehta, Member at BSE & NSE is of the view that one may prefer pharmaceutical stocks.

    • Buy Sun Pharmaceutical, says Sukhani

      According to Sudarshan Sukhani of s2analytics.com, one may buy Sun Pharma.

    • Buy pharma stocks on dips for long term: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy pharma stocks on dips for long term.

    • Stay invested in Sun Pharma, says Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one may stay invested in Sun Pharma.

    • Go long in Sun Pharma, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can go long in Sun Pharma.

    • Prakash Gaba's stock picks that can fetch handsome returns

      Prakash Gaba of prakashgaba.com is of the view that Asian Paints may test Rs 865 and Tata Steel may test Rs 252.

    • Buy Sun Pharma, short HDFC: Hemant Thukral

      Hemant Thukral of Aditya Birla Money is of the view that one can buy Sun Pharma and short HDFC.

    • Bull's Eye: Buy SPARC, BEL, NCC, Sun Pharma, LIC Housing

      Dharmesh Kant of India Nivesh Securities is of the view that one may buy NCC with a target of Rs 90.

    • Buy Sun Pharma, target Rs 790-800: Rahul Mohindar

      Rahul Mohindar of viratechindia.com recommends buying Sun Pharma with a target of Rs 790-800.

    • Buy Sun Pharma, target Rs 820-840: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying Sun Pharma with a target of Rs 820-840.

    • Sales data push Tata Motors, TVS Motor, Hero Moto in top 10

      CNBC-TV18's research teams gets the list of those 10 stocks which are likely to remain in today's trading zone

    • Go long in ICICI Bank, ITC: Amit Harchekar

      Amit Harchekar of A Plus Analytics recommends going long in ICICI Bank and ITC.

    • Go long in Sun Pharmaceutical Industries: Prakash Gaba

      Prakash Gaba of prakashgaba.com is of the view that one can continue to go long in Sun Pharmaceutical Industries and feels that the stock may test Rs 751-752.

    • Sun Pharma may rally as Taro not to invest in wind energy

      US subsidiary Taro Pharma in its annual general meeting notice says it has withdrawn proposal worth USD 225 million to invest in wind energy business.

    • Go long in Sun Pharma 700 Put, says Gaurav Bissa

      According to Gaurav Bissa, Derivatives Analyst at LKP Securities, one may go long in Sun Pharmaceutical Industries 700 Put.

    • Exit Sun Pharma at around Rs 800: Nooresh Merani

      Nooresh Merani of Asian Market Securities is of the view that onem ay exit Sun Pharma at around Rs 800.

    • Exit Sun Pharma, says Ashu Madan

      Ashu Madan of Religare Securities advises exiting Sun Pharmaceutical Industries.

    • Go long in Just Dial; short Vedanta: CK Narayan

      CK Narayan, MD of Growth Avenues advises going long in Just Dial and Adani Port.

    • Stay away from Sun Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may stay away from Sun Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347